Neostigmine: Clinical Trials

6 trials for Neostigmine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 not yet recruiting, 1 unknown. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 4, Not yet recruiting 1, Unknown 1

Follow Neostigmine: new trials by email Literature Review of Neostigmine trials Research Report on Neostigmine

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Study Between Intrathecal Magnesium Sulfate, Neostigmine and Fentanyl as Adjuvant for Bubivacaine in Postoperative Analgesia in Lower Abdominal Surgeries
Magnesium Sulfate and Bupivacaine 0.125%, bupivacaine and Neostigmine, fentanyl and bupivacaine - Magnesium Sulfate, Neostigmine
Phase 4Not yet recruitingAssiut University662024-12-012024-11-12
Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex
Neostigmine, Sugammadex - Urinary Retention Postoperative, Laparoscopic Cholecystectomy
Phase 4CompletedUniversity of Texas Southwestern Medical Center2352023-09-112024-10-09
Neostigmine Versus Sugammadex on Renal Functions
Neostigmine, Sugammadex - Sugammadex, Neostigmine
Phase 4UnknownMenoufia University642023-03-012023-10-13
Reversal of Moderate or Superficial Neuromuscular Blockade Induced by Cisatracurium
Reversal of moderate neuromuscular blockade, Reversal of superficial neuromuscular blockade, Two-step reversal - Neostigmine, Neuromuscular Blocking Agents
Phase 4CompletedPontificia Universidade Catolica de Sao Paulo602021-06-012022-05-19
Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine
Sugammadex, Neostigmine - Neuromuscular Blockade Reversal Agent, Sugammadex
Phase 4CompletedSeoul National University Bundang Hospital772020-02-242020-12-24
Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine
Neostigmine, Sugammadex - Neuromuscular Blockade, Sugammadex
Phase 4CompletedKartal Kosuyolu Yuksek Ihtisas Education and Research Hospital1132013-05-012021-10-04

Narrower conditions

Delayed Emergence from Anesthesia (1)  ·  Muscle Weakness (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Postoperative Complications (1)  ·  Signs and Symptoms (1)

Interventions

Neostigmine (5)  ·  Sugammadex (4)  ·  Bupivacaine (1)  ·  Fentanyl (1)  ·  Magnesium Sulfate (1)

Sponsors

Assiut University (1)  ·  Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital (1)  ·  Menoufia University (1)  ·  Pontificia Universidade Catolica de Sao Paulo (1)  ·  Seoul National University Bundang Hospital (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

Brazil (1)  ·  Egypt (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Eduardo T Moro, MD (1)  ·  Jiwon Han, Ms (1)  ·  Tiffany Moon, MD (1)

Results publications

PMID 20876699, PMID 20885293, PMID 26634077, PMID 27746548, PMID 28399799, PMID 29284839, PMID 30622224, PMID 31362883, PMID 32024465, PMID 35016456, PMID 35803751, PMID 37601044, PMID 38429736, PMID 41789933